Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative ...

In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...

From structure confirmation to methodology improvements, making complex natural products has driven innovation in organic ...

AI Cloud 3.1 adds Nvidia Blackwell plus governance tools; catalysts include adoption and Feb 18 earnings. Read more analysis ...

For all of the political chaos that American science endured in 2025, aspects of this country’s research enterprise made it ...

From AI simulations to energy-efficient manufacturing, learn how leaders in academia and industry are conducting responsible, ...

In a groundbreaking development, researchers have unveiled a revolutionary AI-driven periodic table that’s set to transform the landscape of modern ...

LAHORE: Artificial intelligence (AI) is enabling researchers to uncover new cancer applications for widely used medicines by ...

Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.

Evogene ( ($EVGN) ) has shared an announcement. On December 30, 2025, Israel-based Evogene Ltd. announced that it has appointed Dr. Olga Nissan as ...

According to Towards ICT, the global materials informatics market size is calculated at USD 183.51 million in 2026 and is ...